Lung Agenesis

MINNEAPOLIS, Sept. 1, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Randi Leigh Sessoms Lassiter is acknowledged as a Distinguished Healthcare Provider for her contributions to the field of Pediatric Surgery. Dr. Lassiter prepared for her vocation attending the College of William and Mary where she earned a Bachelor's degree. She then attended Duke University and received a Medical Degree; completed a residency at the Medical College of Georgia; and a fellowship at Nicholas Children's Hospital. Continue Reading Randi Leigh Sessoms Lassiter Dr. Lassiter currently works at M Health Fairview Pediatric Specialty Clinic Discovery & M Health Fairview Pediatric Specialty Clinic Woodbury where she practices as a pediatric general surgeon who treats children who have an illness, injury or disease that requires surgery. Her clinical interests include congenital gastrointestinal and abdominal disorders; congenital lung lesion; management of solid tumors in infants and children; pediatric trauma; vascular access; pediatric endocrine surgery; and chest wall deformities. A published author, the doctor maintains professional affiliation with the ACS and APSA. When reflecting on her illustrious career, Dr. Lassiter attributes her success to following her philosophy of giving her patients the highest quality of care without compromise and the support of her mentor, Dr. Robin Hatley. Among the many journals the doctor reads to stay abreast of the latest research, she most enjoys the American Pediatric Surgical Association. Dr. Lassiter has many highlights in her career and considers becoming board certified in 2023 and finishing her fellowship as her greatest career accomplishment. She would like to dedicate this honor to her dear parents, Kaleta and Randolph Lassiter and thank them for their love and support. Aside from her medical pursuits, the doctor enjoys travel and photography. Contact: Katherine Green, 516-825-5634, [email protected] SOURCE The Inner Circle

Nu-Med Plus said it received interim funding to accelerate the completion of its inhaled nitric oxide clinical device designed for congenital pulmonary hypoplasia and neonatal hypoxia therapy. The new funding came under the guidance of Smith Corporate Services, Salt Lake City, Utah-based Nu-Med Plus said. “We are very excited about the amazing interest and attention that our company is experiencing and trust that with this additional capital the company can move quickly toward redefining the INO arena with the completion of our INO clinical device using our conversion technology, which will allow for single treatments for internal and external therapies in numerous medical facilities and services,” CEO Jeff Robins said in a prepared statement. Nu-Med Plus said research is being undertaken to explore other uses for the device and applications that require vasodilation and increased delivery of oxygen to diseased and injured tissue. The company said its small, multi-dose in-development INO clinical device is being designed to be able to deliver high-purity inhaled nitric oxide in single-dose treatments for therapeutic uses.